EMILY LAUSTSEN: Open Payments
NPI 1033345913 · BERLIN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,161 in 83 payments from 21 companies in 2025. Trend: 2023 $2,906 · 2024 $2,705 · 2025 $2,161
Food & beverage: $2,044Education: $117
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 9 | $285 |
| UCB, Inc. | 8 | $257 |
| Genentech USA, Inc. | 10 | $237 |
| PFIZER INC. | 8 | $201 |
| Amgen Inc. | 7 | $180 |
| ABBVIE INC. | 6 | $166 |
| Neurelis, Inc. | 7 | $124 |
| Eisai Inc. | 4 | $114 |
| Lilly USA, LLC | 4 | $98 |
| Biogen, Inc. | 3 | $69 |
Products named: Ocrevus Zunovo, NURTEC ODT, AUSTEDO XR, Rystiggo, UPLIZNA, VALTOCO, Leqembi, QULIPTA.
Industry payments across MD — which companies pay providers there.
